T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Trimble
TRMB
$13.4B
| $22.2M | ﹤0.01% |
344,742
+5,076
| +1% | +$289K |
|
952
Transmedics
TMDX
$3.11B
| $22M | ﹤0.01% |
297,324
+22,223
| +8% | +$1.83M |
|
953
Huazhu Hotels Group
HTHT
$12.5B
| $22M | ﹤0.01% |
567,606
+551,040
| +3,326% | +$19.2M |
|
954
Visteon
VC
$2.86B
| $21.7M | ﹤0.01% |
184,086
-75,992
| -29% | -$8.87M |
|
|
SFBS
955
ServisFirst Bancshares
SFBS
$5B
| $21.6M | ﹤0.01% |
325,796
-64,021
| -16% | -$4.07M |
|
956
Oric Pharmaceuticals
ORIC
$1.42B
| $21.5M | ﹤0.01% |
1,566,736
+915,175
| +140% | +$10.9M |
|
957
Snap-on
SNA
$20.9B
| $21.5M | ﹤0.01% |
72,523
+419
| +0.6% | +$119K |
|
958
NRG Energy
NRG
$25.2B
| $21.4M | ﹤0.01% |
316,844
-2,813,268
| -90% | -$158M |
|
959
Albemarle
ALB
$15.4B
| $21.4M | ﹤0.01% |
162,386
+2,309
| +1% | +$284K |
|
960
WEX
WEX
$6.78B
| $21.2M | ﹤0.01% |
89,125
-5,758
| -6% | -$1.24M |
|
|
WBA
961
DELISTED
Walgreens Boots Alliance
WBA
| $21.1M | ﹤0.01% |
973,637
+1,740
| +0.2% | +$38.7K |
|
962
A.O. Smith
AOS
$8.49B
| $21M | ﹤0.01% |
234,598
-9,922
| -4% | -$818K |
|
963
Bentley Systems
BSY
$11B
| $20.9M | ﹤0.01% |
401,055
+6,235
| +2% | +$314K |
|
|
JBTM
964
JBT Marel
JBTM
$6.1B
| $20.9M | ﹤0.01% |
199,504
-145,213
| -42% | -$14.5M |
|
965
Rhythm Pharmaceuticals
RYTM
$7.99B
| $20.9M | ﹤0.01% |
481,533
-90,764
| -16% | -$3.97M |
|
966
Lamb Weston
LW
$7.39B
| $20.9M | ﹤0.01% |
195,836
+1,400
| +0.7% | +$146K |
|
967
Molson Coors Class B
TAP
$7.85B
| $20.7M | ﹤0.01% |
307,393
+56,584
| +23% | +$3.59M |
|
968
Mid-America Apartment Communities
MAA
$15.6B
| $20.5M | ﹤0.01% |
155,906
+492
| +0.3% | +$64K |
|
|
PRFT
969
DELISTED
Perficient Inc
PRFT
| $20.5M | ﹤0.01% |
364,068
-37,742
| -9% | -$2.47M |
|
970
AXIS Capital
AXS
$7.3B
| $20.5M | ﹤0.01% |
315,018
+167,114
| +113% | +$10M |
|
|
K
971
DELISTED
Kellanova
K
| $20.4M | ﹤0.01% |
356,803
+4,263
| +1% | +$235K |
|
|
OLK
972
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $20.4M | ﹤0.01% |
868,294
+2,098
| +0.2% | +$50.6K |
|
973
Donnelley Financial Solutions
DFIN
$1.22B
| $20.4M | ﹤0.01% |
328,664
+302,957
| +1,179% | +$18.9M |
|
974
Quest Diagnostics
DGX
$26.1B
| $20.3M | ﹤0.01% |
152,384
-2,451,774
| -94% | -$318M |
|
975
Bunge Global
BG
$21.7B
| $20.3M | ﹤0.01% |
197,821
+5,635
| +3% | +$527K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.